Please login to the form below

Not currently logged in

Celgene names general manager for UK and Ireland

Wim Souverijns replaces Samantha Pearce
Wim Souverijns

Celgene has promoted Wim Souverijns to general manager for its operations in the UK and Ireland.

Souverijns replaces Samantha Pearce, who has moved to a new role at Celgene as VP and general manager for emerging markets in the EMEA region.

Souverijns joined Celgene in 2007 as head of the European marketing operations team. He later moved to a position in the US before returning to Europe to his most recent role as general manager for the Nordics region.

Commenting on his appointment, Souverijns said: “I am excited to have the opportunity to build on recent successes and commit to engage in a collaborative partnership with patients, clinicians, payers and other stakeholders to ensure that all eligible patients have access to our treatments.

“This is even more pertinent with the recent changes to the Cancer Drugs Fund, which I strongly hope will enable patients with myeloma and metastatic pancreatic cancer to continue to be able to access treatments that can make a real difference to their lives.”

Celgene said Souverijns will look to strengthen the firm's relationship with the NHS and other important external partners to highlight the positive effect the industry has on patients and their families.

9th December 2014


Featured jobs

Subscribe to our email news alerts


Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...